6 research outputs found
Description of studies of tuberculosis after hematopoietic stem cell transplantation published from 1990 to January 2015.
<p>Description of studies of tuberculosis after hematopoietic stem cell transplantation published from 1990 to January 2015.</p
Clinical characteristics of patients with tuberculosis after allogeneic hematopoietic stem cell transplantation.
<p>Clinical characteristics of patients with tuberculosis after allogeneic hematopoietic stem cell transplantation.</p
Overall characteristics of allogeneic hematopoietic stem cell transplantation recipients with or without tuberculosis.
<p>Overall characteristics of allogeneic hematopoietic stem cell transplantation recipients with or without tuberculosis.</p
Risk factors for tuberculosis in patients after allogeneic hematopoietic stem cell transplantation.
<p>Risk factors for tuberculosis in patients after allogeneic hematopoietic stem cell transplantation.</p
Cumulative incidence of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients with and without chronic graft-versus-host-disease.
<p>Extensive chronic GVHD was associated with the development of TB (<i>P</i> = 0.003) There is a 4.89 ± 1.32% probability of having TB disease at 1000 days after allogeneic HSCT for extensive chronic GVHD and 1.42 ± 0.50% for limited or without chronic GVHD. cGVHD, chronic graft-versus-host disease; HSCT, hematopoietic stem cell transplantation; TB, tuberculosis.</p
Isoniazid prophylaxis and tuberculosis.
<p>INH prophylaxis did not significantly reduce the incidence of TB (<i>P</i> = 0.548). Among 5 TB patients in group B, one patient had INH prophylaxis. IGRA negative included indeterminate results. IGRA, interferon-γ release assays; INH, isoniazid; TB, tuberculosis.</p